SAN JOSE, Calif.--(BUSINESS WIRE)--Chronix Biomedical today announced publication of a study that supports the utility of its serum DNA blood tests to predict clinical status and monitor disease ...
Hemispherx and Chronix Plan Studies to Validate Technology as a Potential Diagnostic Test for CFS SAN JOSE, Calif., March 3, 2011 (GLOBE NEWSWIRE) -- Chronix Biomedical ("Chronix") announced today ...
IRVINE, Calif., Feb. 02, 2021 (GLOBE NEWSWIRE) -- Oncocyte Corporation (NYSE American: OCX), a molecular diagnostics company with a mission to provide actionable answers at critical decision points ...
Enabled Chronix to Complete Proof-of-Concept Studies Confirming Its Serum DNA Biomarkers Can Accurately Detect Early Stage Cancer and to File Two Key Patents SAN JOSE, Calif.--(BUSINESS WIRE)-- ...
SAN JOSE, Calif.--(BUSINESS WIRE)--Chronix Biomedical today announced that it is partnering with the University of Calgary to develop a commercial version of its serum DNA-based blood test for the ...
Chronix Biomedical has announced that it will launch a new disease detection and monitoring service for cancer researchers at the upcoming 2010 ASCO Annual Meeting. The “For Investigational Use Only” ...
San Jose, California, June 23, 2009 – Chronix Biomedical today reported that a new study in a peer-reviewed journal further confirms the potential diagnostic and prognostic utility of using ...
San Jose, California, April 6, 2010 – Chronix Biomedical today announced publication of a study that supports the utility of its serum DNA blood tests to predict clinical status and monitor disease ...
─Advanced DNA Sequencer Allows Chronix to Speed Up and Expand Development of Its Serum DNA Biomarkers for Early Diagnosis and Monitoring of Cancer and Other Chronic Diseases─ ─New Sequencing ...
Chronix Biomedical, a diagnostic test development company that has operated mostly in secret since its 2000 inception, has finally come out of its shell — publishing information on its product in ...
Chronix Biomedical today announced publication of a study that supports the utility of its serum DNA blood tests to predict clinical status and monitor disease activity and response to treatment in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results